Last Updated on October 30, 2025 by The Health Master
Antimicrobials
In an unprecedented move for animal and public health, the import, manufacture, sale, and distribution of major classes of critical antimicrobials (antiviral and antibiotics) for animal use has officially been banned in India, encompassing a great many of the drug types that serve as last-resort medications for humans.
The notification by Health Ministry, which was made official on September 23, 2025 comes in light of the growing national and international need for antimicrobial resistance (AMR) prevention, infection control and mitigation of the danger posed by resistant pathogens.
Why Address Antimicrobial Resistance (AMR)?
Antimicrobial resistance is a silent pandemic. When microbes no longer respond to the drugs designed to kill them, we find ourselves left with ‘superbugs.’
If powerful, last-resort antibiotics are used in animal husbandry, antimicrobials and resistance only increase.
In addition, these resistant microbes can pass through the human food chain or environment to humans, rendering human antibiotics and antivirals useless.
Antimicrobial Resistance (AMR) and Ban Release
Following a draft notification in May 2025, the Ministry of Health and Family Welfare decided on swift release.
In addition, it was noted that “safer alternatives to the said drugs for animal use are available.”
Thus, there will be no impact on animal well-being; veterinarians and the agriculture industry will be supported in this transition.
The decision was made in consultation with the Drugs Technical Advisory Board (DTAB), ensuring a scientifically supported determination that serves the best interests of public health.
What Life-Saving Medications Are Banned?
While exact articles or numbers were not published, the new notification released banned classes of drugs that are otherwise life-saving for serious infections in humans.
As such, India seeks to preserve their usefulness in humans but absolves their need in animals.
The following antibiotics, antivirals, and antiprotozoals are banned:
- Last-Resort Antibiotics: These include entire classes based on their utility in resistant bacteria situations
- Carbapenems (Doripenem) and Penems (Imipenem—last resort penicillins)
- Glycopeptides (Vancomycin) and Lipopeptides (Daptomycin)—associated with MRSA infections
- Oxazolidinones ( Linezolid-like antibiotics)
- Some Cefazolin (Cephalosporins)
- Ceftobiprole (5th generation Cephalosporin)
- Ceftaroline (for skin infections)
- Various forms of Penicillin
- Essential Antivirals: These include a range of antivirals to treat viral infection in humans.
- Oseltamivir (Tamiflu), Ribavirin, Molnupiravir (current COVID treatment)—now prohibited from use in animals for any reason.
- Specific Antiprotozoals: Any anti-parasitic that also works as an antiviral will not be permitted.
- Nitazoxanide
List of Antimicrobials Banned:
Antibiotics (15 classes/drugs):
- Ureidopenicillins
- Ceftobiprole
- Ceftaroline
- Siderophore cephalosporins
- Carbapenems
- Penems
- Monobactams
- Glycopeptides
- Lipopeptides
- Oxazolidinones
- Fidaxomicin
- Plazomicin
- Glycylcyclines
- Eravacycline
- Omadacycline
Antivirals (18 drugs):
- Amantadine
- Baloxavir marboxil
- Celgosivir
- Favipiravir
- Galidesivir
- Lactimidomycin
- Laninamivir
- Methisazone/Metisazone
- Molnupiravir
- Oseltamivir
- Peramivir
- Ribavirin
- Rimantadine
- Tizoxanide
- Triazavirin
- Umifenovir
- Zanamivir
- Nitazoxanide
Antiprotozoal (1 drug):
- Nitazoxanide
Why is This Important for Public Health Policy?
This international statement reaffirms the Indian government’s plan toward One Health, or the idea that human health is fundamentally connected to animal and environmental health.
- Saving Human Treatments: By stopping the use of these life-saving antibiotics in animals, the Indian government can be assured that these powerful drugs remain functional for humans facing life-threatening infections.
- Safer Alternatives Acknowledged: The fact that the government understands “safer alternatives” to the drugs encourage veterinarians and farmers alike to practice better hygiene/disease prevention with greater opportunities for containment than recalcitrant treatment. The animal health product industry should see innovations because of this possibility.
- Stronger Regulation: Using powers under the Drugs and Cosmetics Act, 1940 (Sections 10A and 26A) shows how Indian Public Health policy places public safety first by consulting the Drugs Technical Advisory Board among others.
Q. What is the main purpose of the Antimicrobials Ban?
The ultimate goal is to preserve the functioning of these critical life-saving antimicrobial (antibiotics and antivirals) drugs through prohibition of their possession/use in animals. This is an important point in time for international efforts against the development of antimicrobial resistance (AMR).
Q. What drugs are now prohibited for use in animals?
Many entire classes of drugs are now prohibited for this reason, including crucial last-resort antibiotics like Carbapenems Glycopeptides and Oxazolidinones as well as a long list of important human Antivirals like Oseltamivir and Molnupiravir. Officially, 35 items in total are noted from each category.
Disclaimer: This article contains information obtained from the source mentioned below. Our team made changes in the format to rewrite and present the news or article in a unique format.
Disclaimer: The information we have provided is for general knowledge and for informational purpose only and it cannot be treated as medical advice. Always consult your doctor for any health issues and / or for the treatment of the same. The Health Master does not claim responsibility for this information.
India to Ban 34 Antimicrobials for animal use
42 Companies banned over supply of NSQ drugs: Rajasthan
DTAB recommends ban on 34 antimicrobials for animal use
DTAB recommends Ban on 16 Fixed Dose Combinations
Pharmaceutical record keeping
49 new Drug Inspectors join in CDSCO
USFDA Inspection: At Jubilant with Zero observations
USFDA issued Form 483 to Lupin with 4 observations: Pune
Drug alert: 94 drug samples declared as NSQ in August 2025
USFDA issued Form 483 to Lupin with 6 observations: Nagpur
Haryana: ₹5,000 Crore investment Plan for Pharma and Medical Device
CDSCO Redefines Cocrystals as ‘New Drugs’
NPPA fixed retail price of 9 formulations: September 2025
USFDA issued Form 483 to Reddy’s with 5 observations: Hyderabad
